TrialCancer research communications2026

A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden.

Christine Federspiel Secher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.